Cargando…
COVID-19 vaccination and Atypical hemolytic uremic syndrome
INTRODUCTION: COVID-19 vaccination has been associated with rare but severe complications characterized by thrombosis and thrombocytopenia. METHODS AND RESULTS: Here we present three patients who developed de novo or relapse atypical hemolytic uremic syndrome (aHUS) in native kidneys, a median of 3...
Autores principales: | Bouwmeester, Romy N., Bormans, Esther M.G., Duineveld, Caroline, van Zuilen, Arjan D., van de Logt, Anne-Els, Wetzels, Jack F.M., van de Kar, Nicole C.A.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755835/ https://www.ncbi.nlm.nih.gov/pubmed/36531998 http://dx.doi.org/10.3389/fimmu.2022.1056153 |
Ejemplares similares
-
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
por: Wijnsma, Kioa L., et al.
Publicado: (2018) -
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
por: Wijnsma, Kioa L., et al.
Publicado: (2019) -
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study
por: Bouwmeester, Romy N., et al.
Publicado: (2022) -
The genetics of atypical hemolytic uremic syndrome
por: Feitz, Wouter J. C., et al.
Publicado: (2018) -
Outcome of atypical haemolytic uraemic syndrome relapse after
eculizumab withdrawal
por: Duineveld, Caroline, et al.
Publicado: (2020)